NEW YORK, May 29, 2024 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may seek additional disclosures or other relief on behalf of the shareholders of these companies. Kuehn Law is investigating whether the Boards of the below companies 1) acted to maximize shareholder value, 2) failed to disclose material information, and 3) conducted a fair process: Surmodics, Inc. has entered into a definiti ...

NEW YORK, May 28, 2024 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Atrion Corporation (NASDAQ: ATRI) and its board of directors concerning the proposed acquisition of the company by Nordson Corporation. Stockholders will receive $460 for each share of Atrion stock that they hold. The transaction is valued at approximately $815 million and is expected to close in the third quarter of 2024.If you are a stockholder of Atrion Corporation and are interested in obtainin ...

MILWAUKEE, May 28, 2024 /PRNewswire/ -- Ademi LLP is investigating Atrion (Nasdaq: ATRI) for possible breaches of fiduciary duty and other violations of law in its transaction Nordson.Click here to learn how to join the https://www.ademilaw.com/case/atrion-corporation or call Guri Ademi toll-free at 866-264-3995.  There is no cost or obligation to you.In the transaction, Atrion's stockholders receive $460.00 per share in cash for each share of Atrion common stock they own. Atrion insiders receive substantia ...

ALLEN, Texas, May 28, 2024 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI), a developer and manufacturer of products primarily for medical applications, today announced that it has entered into an agreement and plan of merger with Nordson Corporation pursuant to which Nordson will acquire Atrion for $460 per share in cash, representing a total equity value of approximately $815 million. The transaction enterprise value reflects a multiple of 20.2 times Atrion’s 2023 EBITDA, and the $460 per share pric ...

ALLEN, Texas, May 21, 2024 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) today announced that its Board of Directors declared a quarterly dividend of $2.20 per share on its outstanding shares of Common Stock. This dividend will be payable on June 28, 2024 to stockholders of record at the close of business on June 14, 2024. Atrion Corporation develops and manufactures products primarily for medical applications. The Company’s website is www.atrioncorp.com. Contact: Cindy FergusonVice President and Ch ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 for the Quarterly Period Ended March 31, 2024 or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the Transition Period from to Commission File Number 001-32982 Atrion Corporation (Exact Name of Registrant as Specified in its Charter) Delaware 63-0821819 (State or Other Jurisdiction of Incorpo ...

EXHIBIT 99.1 Atrion Reports First Quarter 2024 Results ALLEN, Texas, May 10, 2024 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) today announced its results for the first quarter ended March 31, 2024. Revenues for the first quarter of 2024 totaled $47.3 million compared to $40.0 million for the same period in 2023. For the just ended quarter, operating income was $3.1 million, down $1.3 million from the comparable 2023 period, primarily due to a one-time inventory write-off, and net income was $2.8 m ...

公司业务及财务状况 - 公司主要产品用于医疗应用，涉及流体输送、心血管和眼科市场，2023年销售额中约37%来自美国以外市场[163] - 2023年公司营收为1.69326亿美元，较2022年下降8%[170] - 2023年净利润为1.94亿美元，每股基本和稀释收益分别为11.02美元和11.02美元，较2022年净利润下降44%[169] - 2023年毛利为6240万美元，毛利率为37%，较2022年下降4个百分点[172] - 2023年研发费用增加120万美元，销售费用增加10万美元，总务及行政费用增加230万美元[173] - 2023年营业利润为2.26亿美元，较2022年下降43%[175] - 2023年利息和股息收入为800万美元，较2022年下降20%[176] - 2023年其他投资收益为900万美元亏损，较2022年亏损增加70%[177] - 2023年所得税费用为300万美元，有效税率为13.2%，预计2024年有效税率约为14%[178] - 公司在2023年的销售收入中，来自美国以外客户的比例为37%[273] 公司财务状况详情 - 2023年，Atrion Corporation的营收为169,326千美元，较上一年下降了7.7%[205] - 2023年，Atrion Corporation的净利润为19,411千美元，较上一年下降了44.6%[205] - 2023年，Atrion Corporation的现金及现金等价物为3,565千美元，较上一年下降了24.6%[207] - 公司在2023年实现营收为169,326,000美元，较2022年的183,506,000美元有所下降[205] - 净利润为19,411,000美元，较2022年的35,008,000美元有所下降[205] - 现金及现金等价物为3,565,000美元，较2022年的4,731,000美元有所下降[206] - 库存为82,307,000美元，较2022年的65,793,000美元有所增加[206] - 公司截至2023年12月31日的总负债和股东权益为260,825千美元[207] - 公司2023年的净利润为19,411千美元，较2022年的35,008千美元和2021年的33,055千美元有所下降[207] - 公司2023年的现金及现金等价物为3,565千美元，较2022年的4,731千美元有所下降[207] - 公司2023年的库存总额为82,307千美元，较2022年的65,793千美元有所增加[214]

营收情况 - 2023年第四季度，Atrion 公司的营收为4358.4万美元，较2022年同期增长了72.9万美元[2] - 2023年全年，Atrion 公司的营收为1.69326亿美元，较上一年减少1420万美元，净收入为1.9411亿美元，较上一年减少1560万美元[3] - 2024年，Atrion 公司预计营收将高位单位数增长，回到或接近2022年创纪录水平，同时引入新技术到市场，现有客户实现库存合理化[4]